Financial Comparison
Johnson & Johnson vs Medtronic plc
Click a ticker to view the full analysis.
In short
Johnson & Johnson is the more profitable of the two, keeping 28.5% of revenue as net profit against 13.2% for Medtronic plc. Johnson & Johnson trades at the higher trailing P/E (39.1× vs 21.6× for Medtronic plc), so investors pay more for each dollar of its earnings. Fisclear flags 1 medium- or high-severity risk for Johnson & Johnson and 0 for Medtronic plc.
Based on filings for periods ending 27 Sept 2026 (JNJ) and 31 Jul 2026 (MDT) · Updated
FisclearScore Comparison
FisclearScore is a quantitative model. JNJ shown solid · MDT shown dashed. Not financial advice.
| Metric | JNJ | MDT |
|---|---|---|
| Price | $257.78 | $87.75 |
| Market Cap | $621.2B | $112.2B |
| P/E (TTM) | 39.1x | 21.6x |
| P/B | 7.3x | 2.2x |
| Beta | 0.21 | 0.57 |
| Div Yield | 2.07% | 3.13% |
| Revenue (TTM) | $94.2B | $36.4B |
| Net Income | $26.8B | $4.8B |
| Gross Margin | 67.9% | — |
| Risk Flags | 1 flag | — |
Related comparisons
Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.